NCT00784862View on ClinicalTrials.gov

ATAC - Pharmacokinetics (PK) Sub-Protocol

PHASE3CompletedINTERVENTIONAL

Enrollment

9,358

Participants

Timeline

Start Date

June 30, 1998

Study Completion Date

March 31, 1999

Conditions

Breast Cancer

Interventions

DRUG

Anastrozole

1mg, orally, once daily

DRUG

Tamoxifen

20mg, orally, once daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY